Asitri Dashboard Search Clinical Trials
The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.
Saved Searches
Choose Search
Basic Search
Clinical Trials Search Results
Search History:
Count: 201
Selected: 0
| NCT ID | Title | ||
|---|---|---|---|
| NCT05884801 | Phase I Study of QLS1103 in Subjects With Advanced Solid Tumors | ||
| NCT06446388 | Study of QLS31905 and/or QL1706 Combination With Chemotherapy in the Advanced Malignant Solid Tumors | ||
| NCT04234594 | Comparing the Pharmacokinetic and Safety of QL1203 and Vectibix® in Healthy Males. | ||
| NCT06880276 | Efficacy and Safety Study of QLM3003 Ointment in Participants With Mild or Moderate Atopic Dermatitis | ||
| NCT06616571 | Compare the Efficacy and Safety of QL0605 Injections at Different Timepoints | ||
| NCT07344051 | A Phase II Study of QLS12010 Capsules in Adults With Moderate to Severe Atopic Dermatitis | ||
| NCT05973149 | Trial of QLH12016 in Patients With Metastatic Castration Resistant Prostate Cancer | ||
| NCT06254235 | Bioequivalence Study of Two Octreotide Microsphere Formulations in Healthy Volunteers | ||
| NCT07138885 | A Phase II, Single-Arm, Prospective Trial on the Efficacy and Safety of QL1706 Combination Regimen as Second-Line Therapy for Targeted-Immunotherapy-Resistant Hepatocellular Carcinoma | ||
| NCT03267654 | Gefitinib With Chemotherapy or Anti-angiogenesis in NSCLC Patients With Bim Deletion or Low EGFR Mutation Abundance | ||
| NCT06261359 | A Study of CEND-1 With Chemotherapy as First-Line Therapy in Patients With Pancreatic Ductal Adenocarcinoma | ||
| NCT05487391 | A Study of QL1706 Combined With Platinum-containing Chemotherapy in Adjuvant Treatment of Stage II-IIIB Non-small Cell Lung Cancer After Complete Surgical Resection. | ||
| NCT04954456 | A Study of Bispecific Antibody QLS31901 in Patients With Advanced or Metastatic Malignancies | ||
| NCT04550949 | To Evaluate the Efficacy and Safety of QL1206 and Xgeva in Patients With Bone Metastases From Solid Tumors | ||
| NCT05629949 | A Multicenter, Double-blind, Randomized, Parallel-group, Phase III Study of the Efficacy and Safety of QL1701 Plus Docetaxel Versus Herceptin® Plus Docetaxel as First Line Therapy in Patients With HER2-positive Metastatic Breast Cancer | ||
| NCT03651947 | Comparing of the Pharmacokinetic, Safety and Pharmacodynamic of QL1206 and Xgeva® in Healthy Adults | ||
| NCT03169335 | Efficacy and Safety of QL1101 and Avastin® Respectively Combined With Paclitaxel and Carboplatin in the First-line Treatment of Non-squamous Non-small Cell Lung Cancer | ||
| NCT05932888 | Safety, Tolerability, and Pharmacokinetic Study of QLM3003 in Healthy Adult Subjects | ||
| NCT07040826 | Lifitegrast Eye Drops in Healthy Subjects：Phase I Study | ||
| NCT06940336 | To Evaluate the Efficacy and Safety of Tafamidis Meglumine Soft Capsules in the Treatment of Adult Patients With Transthyretin Amyloid Polyneuropathy | ||
| NCT07089186 | Study to Assess the Efficacy and Safety of Meropenem and Pralurbactam in Carbapenem-Resistant Enterobacteriaceae Infections | ||
| NCT03750916 | Anlotinib Combined With Docetaxel for Advanced Non-squamous Non-Small Cell Lung Cancer | ||
| NCT06954116 | Iparomlimab and Tuvonralimab as Neoadjuvant Therapy for Resectable Hepatocellular Carcinoma With High Risk of Recurrence | ||
| NCT06633718 | Study to Assess the Efficacy and Safety of Meropenem and Pralurbactam in CIAI | ||
| NCT02908958 | Clinical Study of Pegylated Somatropin to Treat Children Growth Hormone Deficiency | ||
| NCT05329025 | A Study of QL1706 Combined With Chemotherapy in Advanced Non-small Cell Lung Cancer | ||
| NCT05149924 | Efficacy and Safety of QL1012 in Women for Assisted Reproductive Treatment | ||
| NCT02335879 | Phase III Clinical Study of Domestic Recombinant Human Follitropin for Injection to Treat WHO Class II Anovulation | ||
| NCT05446883 | QL1706 Plus Chemotherapy±Bevacizumab for the First-Line Treatment of Persistent, Recurrent or Metastatic Cervical Cancer | ||
| NCT05823246 | Safety and Efficacy Study of QLF31907 in Advanced Melanoma and Urothelial Carcinoma | ||
| NCT05058118 | Evaluation of the Safety, Tolerability and Pharmacokinetics of Intravenous FL058 Administered in Healthy Subjects(SAD) | ||
| NCT06456528 | QL0911 for the Treatment of Cancer Treatment-Induced Thrombocytopenia | ||
| NCT07061639 | A Study of QLS5133 Monotherapy in Advanced Solid Tumors | ||
| NCT07327619 | A Study to Evaluate the Efficacy and Safety of Meropenem and Pralurbactam in HABP/VABP | ||
| NCT06980909 | The Food Effect on Pharmacokinetics Study of QLC1101 in Healthy Subjects | ||
| NCT00404989 | Antiretroviral Pregnancy Registry (APR): Multi-sponsor Registry to Detect Any Major Teratogenic Effect Involving Any of the Registry Drugs When Administered to Pregnant People. | ||
| NCT05758519 | A Study to Compare QLS1128 With Placebo in Symptomatic Participants With Mild to Moderate COVID-19 | ||
| NCT05649761 | A Phase I Study of QL1604 in Subjects With Advanced Solid Tumors | ||
| NCT06500507 | A Study of QLS4131 in Patients With Recurrent or Refractory Multiple Myeloma | ||
| NCT06749899 | QL1706 (PD-1/CTLA-4 Bi-specific Antibody) and Chemoradiotherapy in Locoregionally-advanced Nasopharyngeal Carcinoma. | ||
| NCT04157257 | An Study to Evaluate Safety and Efficacy of QL-007 Tablets in Combination With Entecavir or Tenofovir in Patients With Chronic Hepatitis b Who Have Received Nucleoside (Acid) Therapy | ||
| NCT06383767 | A Phase III Study of ESG401 for Locally Advanced or Metastatic HR+/HER2- Breast Cancer | ||
| NCT07300111 | A Study to Evaluate Efficacy and Safety of QLG1218(Daprodustat) in Chinese Hemodialysis (HD)-Dependent Subjects With Anemia Associated With Chronic Kidney Disease (CKD) | ||
| NCT07074236 | Pharmacokinetics and Pharmacodynamics Study | ||
| NCT05461287 | Safety, Tolerability and Pharmacokinetics Study of QLS31904 in Patients With Advanced Solid Tumors | ||
| NCT06954246 | A Study of MHB088C Injection Versus Treatment of Physician's Choice in Subjects With Relapsed Small Cell Lung Cancer | ||
| NCT06852456 | QL1706 in Combination With Neoadjuvant Chemotherapy Versus Neoadjuvant Chemotherapy for Locally Advanced, Resectable Esophageal Squamous Cell Carcinoma | ||
| NCT07327697 | A Comparative Phase 1 Study to Evaluate the Pharmacokinetic and Safety of QL2302 vs. Tezspire® in Healthy Subjects | ||
| NCT05648669 | A Study to Evaluate Safety and Efficacy of Elagolix in Patients With Moderate to Severe Endometriosis-Associated Pain | ||
| NCT05603039 | A Phase Ib/II Trial to Evaluate the Safety and Efficacy of QL1706 in Patients With Advanced Hepatocellular Carcinoma |
